Abstract | OBJECTIVE: This retrospective study was conducted to document the incidence and location of recurrences as well as the rate of side effects following low-dose postoperative high-dose-rate (HDR) brachytherapy in patients with endometrial carcinoma. METHODS: From 1987 to 1993, 122 patients with moderate-risk (78) and high-risk (44) endometrial carcinoma underwent adjuvant vaginal irradiation. All patients received three fractions of 7 Gy specified on the surface of the vaginal cylinder. RESULTS: Relapses occurred in 12 (9. 8%) patients on average after 25.6 months. Seven (5.7%) patients had a sole pelvic recurrence; in 2 (1.6%) of those the relapse was located in the vagina only. Three (2.5%) patients had a pelvic relapse combined with distant metastases. Distant metastases alone were diagnosed in 2 (1.6%) patients. A tumor recurrence was diagnosed in 3 of 78 (3.8%) patients with moderate-risk disease and in 9 of 44 (20.5%) patients with high-risk disease. The estimated 5-year relapse-free survival was 94% for patients with moderate-risk and 74% for patients with high-risk tumors (P = 0.004). Neither severe nor chronic complications were noted. CONCLUSION:
|
Authors | E Weiss, P Hirnle, H Arnold-Bofinger, C F Hess, M Bamberg |
Journal | Gynecologic oncology
(Gynecol Oncol)
Vol. 71
Issue 1
Pg. 72-6
(Oct 1998)
ISSN: 0090-8258 [Print] United States |
PMID | 9784322
(Publication Type: Journal Article)
|
Copyright | Copyright 1998 Academic Press. |
Topics |
- Aged
- Aged, 80 and over
- Brachytherapy
(adverse effects, methods)
- Endometrial Neoplasms
(mortality, pathology, radiotherapy)
- Female
- Humans
- Middle Aged
- Neoplasm Metastasis
(pathology)
- Neoplasm Recurrence, Local
(pathology)
- Radiotherapy, Adjuvant
(adverse effects)
- Retrospective Studies
- Survival Rate
|